keyword
https://read.qxmd.com/read/38635786/primary-large-b-cell-lymphomas-of-immune-privileged-sites
#1
JOURNAL ARTICLE
Mark Roschewski, James D Phelan, Elaine S Jaffe
Diffuse large B-cell lymphoma (DLBCL) encompasses a diverse spectrum of aggressive B-cell lymphomas with remarkable genetic heterogeneity and myriad clinical presentations. Multiplatform genomic analyses of DLBCL have identified oncogenic drivers within genetic subtypes that allow for pathologic subclassification of tumors into discrete entities with shared immunophenotypic, genetic, and clinical features. Robust classification of lymphoid tumors establishes a foundation for precision medicine and enables the identification of novel therapeutic vulnerabilities within biologically homogeneous entities...
April 18, 2024: Blood
https://read.qxmd.com/read/38635644/comprehensive-analysis-of-differentially-expressed-mirnas-in-hepatocellular-carcinoma-prognostic-predictive-significance-and-pathway-insights
#2
JOURNAL ARTICLE
Kayleigh Smith, Dan Beach, Roger Silva, Gyorffy Balazs, Francesca Salani, Francesco Crea
Robust prognostic and predictive factors for hepatocellular carcinoma, a leading cause of cancer-related deaths worldwide, have not yet been identified. Previous studies have identified potential HCC determinants such as genetic mutations, epigenetic alterations, and pathway dysregulation. However, the clinical significance of these molecular alterations remains elusive. MicroRNAs are major regulators of protein expression. MiRNA functions are frequently altered in cancer. In this study, we aimed to explore the prognostic value of differentially expressed miRNAs in HCC, to elucidate their associated pathways and their impact on treatment response...
2024: PloS One
https://read.qxmd.com/read/38635329/increasing-knockin-efficiency-in-mouse-zygotes-by-transient-hypothermia
#3
JOURNAL ARTICLE
Amine Bouchareb, Daniel Biggs, Samy Alghadban, Christopher Preece, Benjamin Davies
Integration of a point mutation to correct or edit a gene requires the repair of the CRISPR-Cas9-induced double-strand break by homology-directed repair (HDR). This repair pathway is more active in late S and G2 phases of the cell cycle, whereas the competing pathway of nonhomologous end-joining (NHEJ) operates throughout the cell cycle. Accordingly, modulation of the cell cycle by chemical perturbation or simply by the timing of gene editing to shift the editing toward the S/G2 phase has been shown to increase HDR rates...
April 2024: CRISPR Journal
https://read.qxmd.com/read/38634203/a-robust-computational-quest-discovering-potential-hits-to-improve-the-treatment-of-pyrazinamide-resistant-mycobacterium-tuberculosis
#4
JOURNAL ARTICLE
Muhammad Shahab, Gabriel Christian de Farias Morais, Shopnil Akash, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira, Guojun Zheng, Shahina Akter
The rise of pyrazinamide (PZA)-resistant strains of Mycobacterium tuberculosis (MTB) poses a major challenge to conventional tuberculosis (TB) treatments. PZA, a cornerstone of TB therapy, must be activated by the mycobacterial enzyme pyrazinamidase (PZase) to convert its active form, pyrazinoic acid, which targets the ribosomal protein S1. Resistance, often associated with mutations in the RpsA protein, complicates treatment and highlights a critical gap in the understanding of structural dynamics and mechanisms of resistance, particularly in the context of the G97D mutation...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38634106/genome-and-clonal-hematopoiesis-stability-contrasts-with-immune-cfdna-mitochondrial-and-telomere-length-changes-during-short-duration-spaceflight
#5
JOURNAL ARTICLE
J Sebastian Garcia-Medina, Karolina Sienkiewicz, S Anand Narayanan, Eliah G Overbey, Kirill Grigorev, Krista A Ryon, Marissa Burke, Jacqueline Proszynski, Braden Tierney, Caleb M Schmidt, Nuria Mencia-Trinchant, Remi Klotz, Veronica Ortiz, Jonathan Foox, Christopher Chin, Deena Najjar, Irina Matei, Irenaeus Chan, Carlos Cruchaga, Ashley Kleinman, JangKeun Kim, Alexander Lucaci, Conor Loy, Omary Mzava, Iwijn De Vlaminck, Anvita Singaraju, Lynn E Taylor, Julian C Schmidt, Michael A Schmidt, Kelly Blease, Juan Moreno, Andrew Boddicker, Junhua Zhao, Bryan Lajoie, Andrew Altomare, Semyon Kruglyak, Shawn Levy, Min Yu, Duane C Hassane, Susan M Bailey, Kelly Bolton, Jaime Mateus, Christopher E Mason
BACKGROUND: The Inspiration4 (I4) mission, the first all-civilian orbital flight mission, investigated the physiological effects of short-duration spaceflight through a multi-omic approach. Despite advances, there remains much to learn about human adaptation to spaceflight's unique challenges, including microgravity, immune system perturbations, and radiation exposure. METHODS: To provide a detailed genetics analysis of the mission, we collected dried blood spots pre-, during, and post-flight for DNA extraction...
March 2024: Precision Clinical Medicine
https://read.qxmd.com/read/38634045/case-report-highly-response-to-low-dose-brachytherapy-in-recurrent-retroperitoneal-leiomyosarcoma-with-fancd2-frameshift-mutation-a-unique-case-study
#6
Xiao Li Liu, Jinxin Zhao, Xue Min Di, Guohui Cao, Hongtao Zhang, Juan Wang
We report a case of recurrent retroperitoneal leiomyosarcoma in a male who achieved a rapid and robust but transient clinical response to low-dose iodine-125 brachytherapy. A FANCD2 frameshift mutation was detected by gene sequencing in the cancerous tissue.
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628740/uncovering-a-novel-dna-repair-related-radiosensitivity-model-for-evaluation-of-radiotherapy-susceptibility-in-uterine-corpus-endometrial-cancer
#7
JOURNAL ARTICLE
Hainan Yang, Yanru Qiu, Junjun Chen, Jinzhi Lai
BACKGROUND: Uterine corpus endometrial cancer (UCEC) exhibit heterogeneity in their DNA repair capacity, which can impact their response to radiotherapy. Our study aimed to identify potential DNA repair-related biomarkers for predicting radiation response in UCEC. METHODS: We conducted a thorough analysis of 497 UCEC samples obtained from TCGA database. Using LASSO-COX regression analysis, we constructed a radiosensitivity signature and subsequently divided patients into the radiosensitive (RS) and the radioresistant (RR) groups based on their radiosensitivity index...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38627807/fitmusic-leveraging-structural-and-co-evolutionary-data-for-protein-fitness-prediction
#8
JOURNAL ARTICLE
Matsvei Tsishyn, Gabriel Cia, Pauline Hermans, Jean Kwasigroch, Marianne Rooman, Fabrizio Pucci
Systematically predicting the effects of mutations on protein fitness is essential for the understanding of genetic diseases. Indeed, predictions complement experimental efforts in analyzing how variants lead to dysfunctional proteins that in turn can cause diseases. Here we present our new fitness predictor, FiTMuSiC, which leverages structural, evolutionary and coevolutionary information. We show that FiTMuSiC predicts fitness with high accuracy despite the simplicity of its underlying model: it was among the top predictors on the hydroxymethylbilane synthase (HMBS) target of the sixth round of the Critical Assessment of Genome Interpretation challenge (CAGI6) and performs as well as much more complex deep learning models such as AlphaMissense...
April 16, 2024: Human Genomics
https://read.qxmd.com/read/38623065/brca2-polymorphisms-and-breast-cancer-susceptibility-a-multi-tools-bioinformatics-approach
#9
JOURNAL ARTICLE
Haris Jan, Najeeb Ullah Khan, Ayman M Al-Qaaneh, Munazzah Tasleem, Mikhlid H Almutairi, Ijaz Ali
BACKGROUND/AIMS: The main focus of this investigation is to identify deleterious single nucleotide polymorphisms (SNPs) located in the BRCA2 gene through in silico approach, thereby,providing an understanding of potential consequences regarding the susceptibility to breast cancer. METHODS: The GenomAD database was used to identify SNPs. To determine the potential adverse consequences, our study employed various prediction tools, including SIFT, PolyPhen, PredictSNP, SNAP2, PhD-SNP, and ClinVar...
March 24, 2024: Cellular Physiology and Biochemistry
https://read.qxmd.com/read/38621330/a-robust-transformer-based-pipeline-of-3d-cell-alignment-denoise-and-instance-segmentation-on-electron-microscopy-sequence-images
#10
JOURNAL ARTICLE
Jiazheng Liu, Yafeng Zheng, Limei Lin, Jingyue Guo, Yanan Lv, Jingbin Yuan, Hao Zhai, Xi Chen, Lijun Shen, LinLin Li, Shunong Bai, Hua Han
Germline cells are critical for transmitting genetic information to subsequent generations in biological organisms. While their differentiation from somatic cells during embryonic development is well-documented in most animals, the regulatory mechanisms initiating plant germline cells are not well understood. To thoroughly investigate the complex morphological transformations of their ultrastructure over developmental time, nanoscale 3D reconstruction of entire plant tissues is necessary, achievable exclusively through electron microscopy imaging...
April 2, 2024: Journal of Plant Physiology
https://read.qxmd.com/read/38617974/optimized-allele-specific-silencing-of-the-dominant-negative-col6a1-g293r-substitution-causing-collagen-vi-related-dystrophy
#11
JOURNAL ARTICLE
Astrid Brull, Apurva Sarathy, Véronique Bolduc, Grace S Chen, Riley M McCarty, Carsten G Bönnemann
Collagen VI-related dystrophies (COL6-RDs) are a group of severe, congenital-onset muscular dystrophies for which there is no effective causative treatment. Dominant-negative mutations are common in COL6A1 , COL6A2 , and COL6A 3 genes, encoding the collagen α1, α2, and α3 (VI) chains. They act by incorporating into the hierarchical assembly of the three α (VI) chains and consequently produce a dysfunctional collagen VI extracellular matrix, while haploinsufficiency for any of the COL6 genes is not associated with disease...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38614215/integrative-analysis-of-senescence-related-genes-identifies-robust-prognostic-clusters-with-distinct-features-in-hepatocellular-carcinoma
#12
JOURNAL ARTICLE
Sicheng Liu, Yang Meng, Yaguang Zhang, Lei Qiu, Xiaowen Wan, Xuyang Yang, Yang Zhang, Xueqin Liu, Linda Wen, Xue Lei, Bo Zhang, Junhong Han
INTRODUCTION: Senescence refers to a state of permanent cell growth arrest and is regarded as a tumor suppressive mechanism, whereas accumulative evidence demonstrate that senescent cells play an adverse role during cancer progression. The scarcity of specific and reliable markers reflecting senescence level in cancer impede our understanding of this biological basis. OBJECTIVES: Senescence-related genes (SRGs) were collected for integrative analysis to reveal the role of senescence in hepatocellular carcinoma (HCC)...
April 11, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38612473/multiomics-based-feature-extraction-and-selection-for-the-prediction-of-lung-cancer-survival
#13
JOURNAL ARTICLE
Roman Jaksik, Kamila Szumała, Khanh Ngoc Dinh, Jarosław Śmieja
Lung cancer is a global health challenge, hindered by delayed diagnosis and the disease's complex molecular landscape. Accurate patient survival prediction is critical, motivating the exploration of various -omics datasets using machine learning methods. Leveraging multi-omics data, this study seeks to enhance the accuracy of survival prediction by proposing new feature extraction techniques combined with unbiased feature selection. Two lung adenocarcinoma multi-omics datasets, originating from the TCGA and CPTAC-3 projects, were employed for this purpose, emphasizing gene expression, methylation, and mutations as the most relevant data sources that provide features for the survival prediction models...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612454/biochemical-fractionation-of-human-%C3%AE-synuclein-in-a-drosophila-model-of-synucleinopathies
#14
JOURNAL ARTICLE
Khondamir Imomnazarov, Joshua Lopez-Scarim, Ila Bagheri, Valerie Joers, Malú Gámez Tansey, Alfonso Martín-Peña
Synucleinopathies are a group of central nervous system pathologies that are characterized by the intracellular accumulation of misfolded and aggregated α-synuclein in proteinaceous depositions known as Lewy Bodies (LBs). The transition of α-synuclein from its physiological to pathological form has been associated with several post-translational modifications such as phosphorylation and an increasing degree of insolubility, which also correlate with disease progression in post-mortem specimens from human patients...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38607085/residual-cystine-transport-activity-for-specific-infantile-and-juvenile-ctns-mutations-in-a-ptec-based-addback-model
#15
JOURNAL ARTICLE
Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Cystinosis is a rare, autosomal recessive, lysosomal storage disease caused by mutations in the gene CTNS , leading to cystine accumulation in the lysosomes. While cysteamine lowers the cystine levels, it does not cure the disease, suggesting that CTNS exerts additional functions besides cystine transport. This study investigated the impact of infantile and juvenile CTNS mutations with discrepant genotype/phenotype correlations on CTNS expression, and subcellular localisation and function in clinically relevant cystinosis cell models to better understand the link between genotype and CTNS function...
April 6, 2024: Cells
https://read.qxmd.com/read/38606181/osimertinib-in-the-treatment-of-resected-egfr-mutated-non-small-cell-lung-cancer-a-cost-effectiveness-analysis-in-the-united-states
#16
JOURNAL ARTICLE
Gengwei Huo, Ying Song, Wenjie Liu, Xuchen Cao, Peng Chen
Background: In the double-blind phase III ADAURA randomized clinical trial, adjuvant osimertinib showed a substantial overall survival benefit in patients with stage IB to IIIA, EGFR-mutated, completely resected non-small cell lung cancer (NSCLC). We conduct a cost-effectiveness analysis comparing the use of adjuvant osimertinib to placebo in patients with stage IB to IIIA, EGFR-mutated, resected NSCLC. Methods: Based on the results obtained from the ADAURA trial, a Markov model with three-state was employed to simulate patients who were administered either osimertinib or placebo until disease recurrence or completion of the study period (3 years)...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38605929/development-testing-and-validation-of-a-targeted-ngs-panel-for-the-detection-of-actionable-mutations-in-lung-cancer-nsclc-using-anchored-multiplex-pcr-technology-in-a-multicentric-setting
#17
JOURNAL ARTICLE
Jörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, Andreas Bräuninger, Kristin Hartung, Uwe Gerstenmaier, Ralf Marienfeld, Axel Hillmer, Nadine Bohn, Christina Lehning, Ferdinand Ferch, Peter Wild, Stefan Gattenlöhner, Peter Möller, Frederick Klauschen, Andreas Jung
Lung cancer is a paradigm for a genetically driven tumor. A variety of drugs were developed targeting specific biomarkers requiring testing for tumor genetic alterations in relevant biomarkers. Different next-generation sequencing technologies are available for library generation: 1) anchored multiplex-, 2) amplicon based- and 3) hybrid capture-based-PCR. Anchored multiplex PCR-based sequencing was investigated for routine molecular testing within the national Network Genomic Medicine Lung Cancer (nNGM). Four centers applied the anchored multiplex ArcherDX-Variantplex nNGMv2 panel to re-analyze samples pre-tested during routine diagnostics...
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38602053/advances-in-preclinical-assessment-of-therapeutic-targets-for-bladder-cancer-precision-medicine
#18
JOURNAL ARTICLE
Christoph Nössing, Paula Herek, Shahrokh F Shariat, Walter Berger, Bernhard Englinger
PURPOSE OF REVIEW: Bladder cancer incidence is on the rise, and until recently, there has been little to no change in treatment regimens over the last 40 years. Hence, it is imperative to work on strategies and approaches to untangle the complexity of intra and inter-tumour heterogeneity of bladder cancer with the aim of improving patient-specific care and treatment outcomes. The focus of this review is therefore to highlight novel targets, advances, and therapy approaches for bladder cancer patients...
April 11, 2024: Current Opinion in Urology
https://read.qxmd.com/read/38600072/vaccination-impairs-de-novo-immune-response-to-omicron-breakthrough-infection-a-precondition-for-the-original-antigenic-sin
#19
JOURNAL ARTICLE
Jernej Pušnik, Jasmin Zorn, Werner O Monzon-Posadas, Kathrin Peters, Emmanuil Osypchuk, Sabine Blaschke, Hendrik Streeck
Several studies have suggested the imprinting of SARS-CoV-2 immunity by original immune challenge without addressing the formation of the de novo response to successive antigen exposures. As this is crucial for the development of the original antigenic sin, we assessed the immune response against the mutated epitopes of omicron SARS-CoV-2 after vaccine breakthrough. Our data demonstrate a robust humoral response in thrice-vaccinated individuals following omicron breakthrough which is a recall of vaccine-induced memory...
April 10, 2024: Nature Communications
https://read.qxmd.com/read/38595813/research-progress-of-immunotherapy-against-anaplastic-thyroid-cancer
#20
REVIEW
Jiaqian Chen, Zuixuan Xiao, Hongyan Wu
Anaplastic thyroid cancer (ATC) is the most aggressive type of thyroid cancer. While ATC is rare, its mortality is high. Standard treatments, such as surgery, radiotherapy, and chemotherapy, have demonstrated limited efficacy in managing ATC. However, the advent of immunotherapy has significantly improved the prognosis for patients with ATC. Immunotherapy effectively targets and eliminates tumor cells by using the power of the body's immune cells. The neoantigen is an atypical protein generated by somatic mutation, is exclusively observed in neoplastic cells, and is devoid of central tolerance...
2024: Frontiers in Oncology
keyword
keyword
4791
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.